DocDollars

Salix Pharmaceuticals, A Division of Bausch Health Us, LLC

NJ · United States · Reporting entity ID 100000226817

Total reported 2019–2025
$51.7M
#170 of 2,960 reporting companies — 0.1% of all reported industry payments
$51.7M in general payments across 1,087,205 records.

How it breaks down

General payments $51,716,450

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Salix Pharmaceuticals, A Division of Bausch Health Us, LLC reported $51.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #170 of 2,960 reporting companies. All of it was general payments such as consulting, speaking, food and travel. 1,087,205 general payment records were filed.

Common questions about Salix Pharmaceuticals, A Division of Bausch Health Us, LLC

How much has Salix Pharmaceuticals, A Division of Bausch Health Us, LLC paid US doctors?

Salix Pharmaceuticals, A Division of Bausch Health Us, LLC reported $51,716,450 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $51,716,450 in general payments.

How does Salix Pharmaceuticals, A Division of Bausch Health Us, LLC rank among drug and device companies?

It ranks #170 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Salix Pharmaceuticals, A Division of Bausch Health Us, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.